$ALT (+0.92%) is now performing again after the last trial report and crash.

Of course, there is a lot of risk at this early stage.

Let's see how the FDA sees it later on.

Current developments against:

* Obesity and its associated diseases

* MASH (Metabolic Dysfunction-Associated Steatohepatitis)

* Alcohol use disorder (AUD)

* Alcohol-Associated Liver Disease (ALD)

Earnings next week (11.11 - 15.11)

$SHOP (+0.94%)

$SOUN

$MARA (+2.14%)

$BABA (-1.64%)

$CAVA

$SPOT (+1.37%)

$AMAT (+5.39%)

$DIS (-0.11%)

$PLUG (+5.34%)

$HD (+0.11%)

$MNDY (+1.09%)

$OXY (+0.15%)

$RKLB (+1.72%)

$BSEM

$ZETA (+2.13%)

$SE (+0.63%)

$RKT

$CSCO (-0.03%)

$ASTS (+1.72%)

$WULF (+2.08%)

$ONON (+2.43%)

$OKLO

$HUT (+1.7%)

$NVAX (+0.87%)

$HTZ (+1.53%)

$LUNR

$CART

$TALN

$BITF (+9.2%)

$GRAB (+1.2%)

$JD (-1.17%)

$LAZR

$ALT (+0.92%)

$CRON (+0.68%)

$ICL

$NICE

$CYBR (+1.12%)

$BXSL (+0.18%)

$DESP

$ARMK (+0.17%)

$TSN (+0.38%)

$RUM

$PGY

$TGI

$AAP (+0.66%)

$AXSM (+0.13%)

$AZN (-1.14%)

$BILI (-3.38%)

$LINC (+0.86%)

$LQDA (+0.56%)

$ALT (+0.92%) I hope things are looking up😂

$ALT (+0.92%) What do you think of the share?

The share is very exciting and after the drop I am now hoping for a nice return of 20%-30%